First quality-of-life data of a sequential dose-dense regimen in advanced ovarian cancer: A multicenter phase II study of the Northeastern German Society of Gynecological Oncology.

2011 ◽  
Vol 29 (15_suppl) ◽  
pp. 5071-5071
Author(s):  
G. Oskay-Özcelik ◽  
R. Richter ◽  
K. Pietzner ◽  
H. Hindenburg ◽  
H. L. Sommer ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Ovarian Cancer ◽  
German Society ◽  
Life Data ◽  
Multicenter Phase ◽  
Dose Dense

A multicenter phase II study of gemcitabine, paclitaxel, and cisplatin in chemonaïve advanced ovarian cancer

2005 ◽  
Vol 98 (1) ◽  
pp. 134-140 ◽  
Author(s):  
S.K. Gupta ◽  
S. John ◽  
R. Naik ◽  
R. Arora ◽  
B. Selvamani ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Ovarian Cancer ◽  
Multicenter Phase

A multicenter phase II study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer: a GINECO study

2004 ◽  
Vol 53 (6) ◽  
pp. 489-495 ◽  
Author(s):  
V�ronique Di�ras ◽  
Jean Paul Guastalla ◽  
Jean Marc Ferrero ◽  
Herv� Cur� ◽  
B�atrice Weber ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Advanced Ovarian Cancer ◽  
Line Treatment ◽  
First Line ◽  
Multicenter Phase ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document